Thus, we demonstrate cyclosporine treatment of human hepatoma cells to significantly reduce DNA-binding of HNF4α to AGT and AGTR1 at gene specific promoters to cause impaired gene expression. This evidence concerns the gene AGT and hepatocellular carcinoma.